IMV
IMV is a Canadian biopharmaceutical company focused on developing immunotherapies for serious human diseases using its proprietary lipid-based delivery system, which the company calls DPX.
Key facts
| Business Model | Commerce |
|---|---|
| Legal Name | IMV Inc. |
| Company Operating Status | Active |
| Full Address | 130 Eileen Stubbs Avenue, Suite 19 Dartmouth, Nova Scotia, B3B 2C4 Canada |
| Previous Name | Immunovaccine Inc. |
| Stock Symbol | IMV |
| Ticker Symbol | IMV |
Contact details
Email and phone for IMV are available to signed-in members of CliffBio.
Sign in to view